Organizations Filed Purposes:
TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS.
ACCELERATE BRAIN CANCER CURE HAS A SINGLE FOCUS-TO HASTEN THE DISCOVERY OF A CURE FOR BRAIN CANCER.
ACCELERATE BRAIN CANCER CURE, INC. (ABC2) BELIEVES A FOCUSED AND AGGRESSIVE ENTREPRENEURIAL MODEL WILL INCREASE THE NUMBER OF THERAPIES DISCOVERED AND ENABLE THOSE THERAPIES TO BE AVAILABLE TO DOCTORS AND PATIENTS MORE QUICKLY. ABC2 PROVIDES RESEARCHERS WITH THE PIVOTAL SUPPORT THEY NEED TO MAKE CRITICAL BREAKTHROUGHS. IT FUNDS TRANSLATIONAL RESEARCH AIMED AT FINDING THE FASTEST POSSIBLE ROUTE TO A CURE. ABC2 SUPPORTS A RANGE OF MEDICAL RESEARCH ORGANIZATIONS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Max Wallace | PRESIDENT AND CEO | 40 | $536,539 |
| David Sandak | VP/SECRETARY/TREASURER | 40 | $318,748 |
| Gary Wimmer | MEMBER | 1 | $0 |
| Jonathan Weinberg | MEMBER | 1 | $0 |
| Doug Holladay | MEMBER | 1 | $0 |
| Jean Case | CO-FOUNDER | 1 | $0 |
| David Cole | MEMBER | 1 | $0 |
| Nancy Pfund | MEMBER | 1 | $0 |
| Stacey Case | CO-FOUNDER | 1 | $0 |
| Steve Case | CHAIRMAN & CO-FOUNDER | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202003219349306695_public.xml